Published in Medicine (Baltimore) on December 01, 2015
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer (2011) 18.34
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56
Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99
Gastric cancer epidemiology in Korea. J Gastric Cancer (2011) 1.91
Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol (2011) 1.89
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012. Cancer Res Treat (2013) 1.67
Is gastric carcinoma different between Japan and the United States? Cancer (2000) 1.61
Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol (2012) 1.38
Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer (2005) 1.34
Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer (1993) 1.33
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol (2012) 1.09
Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg (2006) 1.07
Recent evolution of surgical treatment for gastric cancer in Korea. J Gastric Cancer (2011) 1.05
A nomogram for predicting individual survival of patients with gastric cancer who underwent radical surgery with extended lymph node dissection. Gastric Cancer (2013) 1.02
Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation. PLoS One (2015) 0.91
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer (2014) 0.89
[Surgical treatment of gastric carcinoma]. Korean J Gastroenterol (2009) 0.79
Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol (2010) 5.51
Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg (2008) 4.95
Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol (2012) 2.97
Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg (2011) 2.92
Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg (2010) 1.84
Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer. Ann Surg Oncol (2011) 1.72
Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc (2009) 1.63
Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol (2010) 1.54
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med (2008) 1.54
Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathways. Int J Mol Sci (2010) 1.53
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51
Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc (2010) 1.51
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol (2009) 1.51
Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol (2006) 1.44
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging (2005) 1.42
Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol (2009) 1.41
Clinical and electrophysiological comparison of different methods of soft tissue coverage of the median nerve in recurrent carpal tunnel syndrome. Neurosurgery (2008) 1.41
Optimal submucosal invasion of early gastric cancer for endoscopic resection. Ann Surg Oncol (2015) 1.39
Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol (2007) 1.26
Characteristics of synchronous cancers in gastric cancer patients. Cancer Res Treat (2006) 1.22
Hepatic splenosis diagnosed as hepatocellular carcinoma: report of a case. Surg Today (2002) 1.22
Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc (2013) 1.22
Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy. Jpn J Clin Oncol (2004) 1.22
Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg (2009) 1.21
Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. J Surg Oncol (2011) 1.18
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Eur J Cancer (2011) 1.17
Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer. Surg Endosc (2011) 1.16
Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc (2012) 1.12
The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study. Surg Endosc (2013) 1.12
Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg (2011) 1.11
Sentinel node mapping and skip metastases in patients with early gastric cancer. Ann Surg Oncol (2009) 1.11
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. Eur J Cancer (2012) 1.11
Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol (2006) 1.10
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol (2012) 1.09
Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. Am J Surg (2013) 1.09
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol (2011) 1.08
Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer (2012) 1.07
Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol (2008) 1.06
Health-related quality of life among disease-free stomach cancer survivors in Korea. Qual Life Res (2006) 1.06
Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma. Ann Surg (2016) 1.05
Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report. J Med Case Rep (2011) 1.05
Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol (2010) 1.04
The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer. Helicobacter (2014) 1.04
Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1. Gastroenterology (2012) 1.03
AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress. Biochem Pharmacol (2009) 1.03
History of minimally invasive surgery for gastric cancer in Korea. J Gastric Cancer (2012) 1.01
Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Ann Surg (2012) 1.01
Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation. Int Immunol (2005) 1.00
Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer (2008) 1.00
Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection. Int J Radiat Oncol Biol Phys (2012) 1.00
Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett (2003) 0.99
Unilateral spondylolysis combined with contralateral lumbar pediculolysis in a military parachutist. J Spinal Disord Tech (2006) 0.99
A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Ann Surg Oncol (2007) 0.99
Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg (2010) 0.98
Delayed carotid wallstent shortening resulting in restenosis following successful carotid artery angioplasty and stenting. J Korean Neurosurg Soc (2009) 0.98
Is Transradial Cerebral Angiography Feasible and Safe? A Single Center's Experience. J Korean Neurosurg Soc (2010) 0.98
Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease. Int J Colorectal Dis (2007) 0.98
Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One (2012) 0.97
Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology (2004) 0.97
E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells. J Cell Sci (2012) 0.96
Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma. Am J Clin Oncol (2005) 0.96
The influence of reconstruction methods on food retention phenomenon in the remnant stomach after a subtotal gastrectomy. J Surg Oncol (2008) 0.96
Cross-cultural adaptation of the korean version of the minneapolis-manchester quality of life instrument-adolescent form. J Korean Med Sci (2013) 0.95
E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Hepatology (2010) 0.95
General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer (2011) 0.94
Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol (2010) 0.94
Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis. J Ginseng Res (2013) 0.94
Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol (2007) 0.94
Angiographic and clinical outcomes of stent-alone treatment for spontaneous vertebrobasilar dissecting aneurysm. Acta Neurochir (Wien) (2010) 0.94
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics (2009) 0.94
Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: results of prospective single center trials. J Surg Oncol (2009) 0.93
Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer (2012) 0.93
Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway. BMC Complement Altern Med (2013) 0.93
Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol (2006) 0.93
Knowledge, attitudes, and practice on second primary cancer screening among cancer survivors: a qualitative study. Patient Educ Couns (2010) 0.92
Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. Am J Clin Oncol (2005) 0.92
Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and β-catenin gene signature predicts survival. PLoS One (2012) 0.92
Health-related quality of life after robot-assisted distal gastrectomy in early gastric cancer. World J Surg (2014) 0.92
Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg (2005) 0.91
Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer. J Gastroenterol Hepatol (2013) 0.91
Transarterial coil embolization of a carotid-cavernous fistula which occurred during stent angioplasty. Acta Neurochir (Wien) (2009) 0.91